Maynard Um
-
-
-
-
-
-
-
Immuneering reports Q1 2026 financial results and clinical updates
-
-
-
-
-
-
-
Leerink Partners Starts Immuneering Corporation (IMRX) at Outperform
-
-
-
-
-
-
-
Immuneering Corporation (IMRX) files for up to 9.18M share offering by selling stockholders
-
-
-
-
-
-
-
Immuneering Corporation (IMRX) Tops Q1 EPS by 5c
-
-
-
-
-
-
-
Immuneering Corporation (IMRX) Granted FDA Fast Track Designation for IMM-1-104
-
-
-
-
-
-
418,486 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

